Can MRI replace CT scans for lung fibrosis in scleroderma?

NCT ID NCT03207997

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a special MRI technique can measure lung stiffness in people with scleroderma, a disease that often causes lung scarring. Researchers enrolled 24 adults and compared MRI results to standard lung function tests. The goal was to see if MRI could offer a safer, radiation-free way to track lung damage.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a safer, radiation-free way to monitor lung scarring in scleroderma patients.
What could go wrong
This is a small feasibility study with only 24 participants, so results may not apply broadly. The MRI technique is still experimental and not yet ready for routine use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCLERODERMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cochin Hospital

    Paris, Paris, 75014, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.